Cargando…
Successful Use of Fosmanogepix for Treatment of Rare Highly Resistant Cutaneous Fusariosis in a Pediatric Patient With STAT3 Hyper-Immunoglobulin E Syndrome and End-Stage Kidney Disease
We describe the successful use of the novel antifungal drug fosmanogepix to treat a chronic case of multidrug-resistant cutaneous Fusarium suttonianum infection in a pediatric patient with STAT3 hyper-IgE syndrome and end-stage kidney disease on peritoneal dialysis.
Autores principales: | Goggin, Kathryn P, Londeree, Jackson, Freeman, Alexandra F, Garro, Rouba, George, Roshan P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249262/ https://www.ncbi.nlm.nih.gov/pubmed/37305844 http://dx.doi.org/10.1093/ofid/ofad285 |
Ejemplares similares
-
S4.1a Fusariosis: MICs, mono versus combination therapy and fosmanogepix
por: Hoenigl, Martin
Publicado: (2022) -
First Reported Case of Invasive Cutaneous Penicillium cluniae Infection in a Patient With Acute Myelogenous Leukemia: A Case Report and Literature Review
por: Mehta, Devanshi, et al.
Publicado: (2021) -
Disseminated Tuberculosis With an Atypical Cutaneous Manifestation in a Hematopoietic Cell Transplant Patient in the Early Posttransplant Period: Case Report and Review of the Literature
por: Czech, Mary M, et al.
Publicado: (2022) -
Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis
por: Alkhazraji, Sondus, et al.
Publicado: (2020) -
Disseminated Mycobacterium avium Complex Myositis in a Patient With Graft-Versus-Host Disease
por: Kompa, Kathryn Grace, et al.
Publicado: (2022)